Innovating Works

FONDAZIONE PENTA ETS

Desconocido
Showing 1 to 20 of 36 results
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3 OPEN LABEL RANDOMISED VACCINE TRIAL OF... Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-26 - 2027-07-31 | Financiado
SUPPORT: Supporting the next generation of African experts on preventing mortality among children living with... The SUPPORT project aims to strengthen health research systems in sub-Saharan African (SSA) countries affected by poverty-related pediatric...
2024-06-11 - 2028-11-30 | Financiado
SNIP-AFRICA: Severe neonatal infection adaptive platform trials in Africa FONDAZIONE PENTA ETS tramitó un HORIZON EUROPE HORIZON-JU-GH-EDCTP3-2022-01 SNIP-AFRICA aims to establish a clinical research network and architecture to implement adaptive platform trials in sub-Saharan Africa (SSA)...
2023-06-07 - 2028-06-30 | Financiado
RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 FONDAZIONE PENTA ETS participó en un HORIZON EUROPE HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado
VERDI: SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts FONDAZIONE PENTA ETS participó en un HORIZON EUROPE HORIZON-HLTH-2021-CORONA-01 Variants of concern (VoC) of SARS-CoV-2 raise the possibility of increases in transmissibility, severity and immune evasion. Children and pr...
2021-11-11 - 2025-10-31 | Financiado
PROMISE: Preparing for RSV Immunisation and Surveillance in Europe FONDAZIONE PENTA ETS participó en un H2020 H2020-JTI-IMI2-2020-22-single-stage RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progre...
2021-05-21 - 2024-04-30 | Financiado
NeoIPC: Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs b... FONDAZIONE PENTA ETS participó en un H2020 H2020-SC1-BHC-2018-2020 Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable po...
2021-02-18 - 2026-03-31 | Financiado
ECRAID-Base: European Clinical Research Alliance on Infectious Diseases FONDAZIONE PENTA ETS participó en un H2020 H2020-SC1-BHC-2018-2020 ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) continues the activities of PREPARE, COMBACTE and ECRAID-Plan, whi...
2021-01-29 - 2026-02-28 | Financiado
ORCHESTRA: Connecting European Cohorts to Increase Common and Effective Response to SARS CoV 2 Pandemic ORCHES... FONDAZIONE PENTA ETS participó en un H2020 H2020-SC1-PHE-CORONAVIRUS-2020-2 The ORCHESTRA project provides an innovative approach to learn from the SARS-CoV-2 health crisis and derive recommendations for increasing p...
2020-11-06 - 2024-11-30 | Financiado
RECoVER: Rapid European SARS CoV 2 Emergency research Response RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing t...
2020-04-08 - 2023-08-13 | Financiado
VALUE-Dx: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use Antimicrobial resistance (AMR) is of great public health concern, causing numerous losses of lives worldwide and threatening to reverse many...
2019-03-25 - 2024-09-30 | Financiado
REACH: REACH Russian European Alliance for research among women Children and adolescents impacted by HIV... FONDAZIONE PENTA ETS tramitó un H2020 H2020-SC1-BHC-2018-2020 Pregnant women, children and adolescents are priority populations in the global public health response to the epidemics of HIV, TB and HCV.T...
2018-12-10 - 2021-06-30 | Financiado
ECRAID-Plan: European Clinical Research Alliance on Infectious Diseases ECRAID Business Plan FONDAZIONE PENTA ETS participó en un H2020 H2020-SC1-BHC-2018-2020 Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious dis...
2018-12-04 - 2021-06-30 | Financiado
c4c: conect4children COllaborative Network for European Clinical Trials For Children FONDAZIONE PENTA ETS tramitó un H2020 H2020-JTI-IMI2-2016-10-two-stage Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currentl...
2018-06-22 - 2025-04-30 | Financiado
ID-EPTRI: Infradev European Paediatric Translational Research Infrastructure FONDAZIONE PENTA ETS participó en un H2020 H2020-INFRADEV-2016-2017 The general objective of this project is to design the framework for the European Paediatric Translational Research Infrastructure (EPTRI),...
2018-01-25 - 2020-04-30 | Financiado
RESCEU: REspiratory Syncytial virus Consortium in EUrope Sofia ref. 116019 FONDAZIONE PENTA ETS participó en un H2020 H2020-JTI-IMI2-2015-06-two-stage RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk gr...
2016-12-14 - 2022-09-30 | Financiado
ZIKAction: ZIKAction Preparedness research and action network on maternal paediatric axis of ZIKV infection i... FONDAZIONE PENTA ETS tramitó un H2020 H2020-SC1-2016-2017 ZIKAction proposes to set up a multidisciplinary research network across Latin America with a focus on maternal and child health to coordina...
2016-11-16 - 2021-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.